Cargando…

Angiotensin receptor blockers retard the progression and fibrosis via inhibiting the viability of (AGTR1+)CAFs in intrahepatic cholangiocarcinoma

BACKGROUND: Intrahepatic cholangiocarcinoma (iCCA) is a highly lethal malignancy characterized by massive fibrosis and has ineffective adjuvant therapies. Here, we demonstrate the potential of angiotensin receptor blockers (ARBs) in targeting iCCA. METHODS: Masson's trichrome staining was used...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jian‐Hui, Wu, Xiao, Ni, Xuhao, Li, Ya‐Xiong, Xu, Long, Hao, Xiao‐Yi, Zhao, Wei, Zhu, Xiao‐Xu, Yin, Xiao‐Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975461/ https://www.ncbi.nlm.nih.gov/pubmed/36855786 http://dx.doi.org/10.1002/ctm2.1213

Ejemplares similares

Pancreatic ductal adenocarcinoma cells regulated the gemcitabine‐resistance function of CAFs by LINC00460
por: Zhu, Xiao‐Xu, et al.
Publicado: (2022)

AGTR1 Inhibits the Progression of Lung Adenocarcinoma
por: Xiong, Lecai, et al.
Publicado: (2021)

MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs
por: Yang, Renjie, et al.
Publicado: (2022)

MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs: Erratum
por: Yang, Renjie, et al.
Publicado: (2022)

Novel discovery of PDPN-positive CAFs contributing to tumor-associated lymphangiogenesis through mesenchymal to lymphatic endothelial transition in intrahepatic cholangiocarcinoma
por: Sha, Meng, et al.
Publicado: (2023)

Preoperative subcategorization based on magnetic resonance imaging in intrahepatic cholangiocarcinoma
por: Xiao, Yuyao, et al.
Publicado: (2023)

High level of CD73 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Xu, Ya-ping, et al.
Publicado: (2021)

Surgical treatment of intrahepatic cholangiocarcinoma: a retrospective study of 104 cases
por: Xun, Xiao-Dong, et al.
Publicado: (2016)

YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation
por: Huang, Chen‐Song, et al.
Publicado: (2022)

Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma
por: Sha, Meng, et al.
Publicado: (2019)

Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
por: Li, Xiao-Long, et al.
Publicado: (2021)

Prognostic Significance of Capn4 Overexpression in Intrahepatic Cholangiocarcinoma
por: Zhang, Chi, et al.
Publicado: (2013)

Is angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy protective against prostate cancer?
por: Mao, Yeqing, et al.
Publicado: (2016)

Expression of VEGFR-3 in intrahepatic cholangiocarcinoma correlates with unfavorable prognosis through lymphangiogenesis
por: Sha, Meng, et al.
Publicado: (2018)

MFAP5 facilitates the aggressiveness of intrahepatic Cholangiocarcinoma by activating the Notch1 signaling pathway
por: Li, Jian-Hui, et al.
Publicado: (2019)

Therapeutic Targeting of CDK7 Suppresses Tumor Progression in Intrahepatic Cholangiocarcinoma
por: Chen, Hua-Dong, et al.
Publicado: (2020)

Proteome Landscapes of Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Yi, Xiao, et al.
Publicado: (2023)

A New Prognostic Model Covering All Stages of Intrahepatic Cholangiocarcinoma
por: Zhou, Shuang-Nan, et al.
Publicado: (2022)

Novel Insights into the Antagonistic Effects of Losartan against Angiotensin II/AGTR1 Signaling in Glioblastoma Cells
por: Panza, Salvatore, et al.
Publicado: (2021)

Case report: immunotherapy successfully treated brain metastasis in intrahepatic cholangiocarcinoma and literature review
por: Xie, Peiyi, et al.
Publicado: (2022)

Renin-angiotensin system inhibitors improve the survival of cholangiocarcinoma: a propensity score-matched cohort study
por: Zhu, Xiao-Xu, et al.
Publicado: (2023)

A case report of rectal adenocarcinoma with intrahepatic cholangiocarcinoma of the liver
por: Guo, Jing-qiang, et al.
Publicado: (2019)

Intrahepatic Sarcomatoid Cholangiocarcinoma
por: Malhotra, Shalini, et al.
Publicado: (2010)

Asbestos and Intrahepatic Cholangiocarcinoma
por: Brandi, Giovanni, et al.
Publicado: (2020)

Management of Intrahepatic Cholangiocarcinoma
por: Kodali, Sudha, et al.
Publicado: (2021)

Re: Is there a difference in the effect between the angiotensin‐converting enzyme inhibitor and angiotensin‐receptor blocker on the COVID‐19?
por: Liu, Xiao, et al.
Publicado: (2020)

Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension
por: Meng, Xiao, et al.
Publicado: (2020)

EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma
por: Hao, Xiao-Yi, et al.
Publicado: (2016)

Characterization and prognostic significance of mortalin, Bcl-2 and Bax in intrahepatic cholangiocarcinoma
por: Kang, Qiang, et al.
Publicado: (2018)

Peritumoral ductular reaction can be a prognostic factor for intrahepatic cholangiocarcinoma
por: Shen, Zhenyang, et al.
Publicado: (2020)

IKKα modulates primary sclerosing cholangitis and intrahepatic cholangiocarcinoma
por: Jiang, Qun, et al.
Publicado: (2014)

Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling
por: Peng, Rui, et al.
Publicado: (2018)

Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge
por: Carotti, Simone, et al.
Publicado: (2021)

Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection
por: Li, Xiao-hui, et al.
Publicado: (2022)

Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension
por: Tian, Ci, et al.
Publicado: (2021)

Molecular docking analysis of AGTR1 antagonists
por: Sayed Murad, Hussam Aly, et al.
Publicado: (2023)

Systemic inflammation score predicts survival in patients with intrahepatic cholangiocarcinoma undergoing curative resection
por: Zhang, Yong, et al.
Publicado: (2019)

The focus clinical research in intrahepatic cholangiocarcinoma
por: Song, Yinghui, et al.
Publicado: (2022)

Case Report: Primary lymphoepithelioma-like intrahepatic cholangiocarcinoma
por: Liu, Fei, et al.
Publicado: (2023)

The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion
por: Meng, Xian-Long, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k4ll4flmk5h50bh9c9qvhe54vr